Press Releases
17 May 2023
The International Society for Pharmaceutical Engineering (ISPE) Foundation Diversity Internship Program with Gilead Sciences, Inc. is proud to announce Laura Chau and Vincent Lai as its 2023 internship recipients. Chau and Lai were chosen from a...
13 June 2023 - 13 June 2023
Technical Tuesday: Development of Innovative Single-Use Bioprocessing Film for Strength and Leak Resistance 13 Jun 2023 5.30-6.30pm SGT | Online Abstract : Single-use system assemblies are increasing in use for Biopharmaceutical production processes...
iSpeak Blog

The ISPE GAMP® Blockchain Special Interest Group is excited to be in its 4th year! For those of you following this space I’m sure you can appreciate the roller coaster of events across crypto, blockchain, and pharma over that time. Yet despite many of the external challenges the core technology behind blockchains has remained secure, available, and immutable – just as they were...

Affiliates/Chapters News & Press Releases
15 May 2023
Share knowledge, personal practices and benchmarks on a specific topic about data, digital, new technologies, computer systems validation, IT compliance, etc. No presentation or slides, just (virtual) connect (via MS TEAMS) with peers discussing...
Press Releases
11 May 2023
ISPE announced the 2023 Facility of the Year Award Winners at the 2023 ISPE Europe Annual Conference in Amsterdam, The Netherlands. The award-winning projects selected by the FOYA program set the standard for pharmaceutical facilities of the future...
Press Releases
11 May 2023
ISPE with partnership of the ISPE Foundation is passionately committed to investing in the future of the pharmaceutical industry through our student and Emerging Leaders programs. ISPE is pleased to announce a unique opportunity for students and...
Press Releases
09 May 2023
The ISPE Foundation Diversity Internship Program, with WuXi Biologics, is proud to announce the 2023 internship recipient: Erin Cooper, who was selected from a highly competitive pool of applicants from across the United States. Cooper is a...
iSpeak Blog

Are you interested in developing a new bioproduct and attracted by the incredible potentials of new modalities like ATMPs, Cell and Gene Therapies, AAVs, oligonucleotides, multi-specificity antibodies, mRNA vaccines, and more? Despite the appeal of these new modalities, there is a significant risk of failure due to the many unknowns associated with these new technologies.

15 June 2023 - 15 June 2023
How does ESG pave a path forward to Carbon Neutrality? ESG Aspirations to reduce carbon footprint- all Speakers ( Edwards, Takeda, Gilead) Operational Practices for a new and or legacy facility to achieve the goals ( We would like to have the...
Subscribe to